OSB delivers a 4-day Executive Education program for Hikma Pharmaceuticals in Morocco

OSB's Executive Education recently delivered the Effective Communications program for Al Jazeera/Hikma Pharmaceuticals’ 37 procurement and purchasing executives from May 1-4.

The program focused on building the capacity of the participants to prepare for and manage crises in the pharmaceuticals setting while developing the needed interpersonal and organizational communication skills and channels. Dr. Nadine Yehya, assistant professor of marketing specialized in crisis communication and management, noted that the program was specifically designed for Hikma to identify sources of risk and the needed communication planning and execution to mitigate possible crises and address business adversities. “Effective communications skills are necessary to prevent a crisis and to handle critical escalating situations in an ethical professional manner. The participants appreciated the emphasis of the program on fortifying their interpersonal communication skills and in equipping them with strategies to adequately communicate during normal business as well as in crises.”

This program demonstrates a clear and tangible commitment from OSB to customize and deliver programs that align with OSB's vision and mission to increase international visibility and become globally recognized as the region's business education leader.

This is one of many examples of OSB bringing business education to the corporate world. Laith Dajani, executive director of Executive Education at OSB, commented, “We created this customized program to address the communication challenges pharmaceutical executives face with both their internal and external stakeholders in their institutions. Working closely with Al Jazeera/Hikma Pharmaceuticals, we designed and customized the program to address concepts and models needed in order to improve communications for pharmaceutical professionals working in the private and public sectors in the region."

Ahmad Abdullah, country manager for UAE and Bahrain at Hikma, praised the interactive sessions presented during the program pointing out the course content as a success factor. “The course was practical, valuable, and helpful. Delegates came back to UAE happy with the new knowledge and skills they learned during the course.”

“For Hikma, the American University of Beirut is the North Star when it comes to quality of education,” said Bashar M. Al-Sheikh Ali, S&M business analyst, Hikma. “This year again, our program on effective communication in healthcare with AUB has been instrumental to our ongoing commitment to development. Hikma’s founder, the late Samih Darwazah, said ‘At Hikma, education isn’t a philosophy, it’s a policy’.”

Hikma Pharmaceuticals, based in London, manufactures branded and non-branded generic and in-licensed pharmaceutical products. They are a leading licensing partner in the MENA region and the company has built a long and successful track record with global licensing partners. Hikma Pharmaceuticals established their branded generic medicine business in the Middle East and North Africa in 1978 and has since grown into a $2bn global generic pharmaceuticals company.